Works cited by this work

19 works

Work: Design, synthesis, biological evaluation of a new tricyclicthiazolopy‐rimidinone derivatives as acetylcholinesterase inhibitors

Design, synthesis, in vitro evaluation of a new pyrrolo[1,2‐a]thiazolo[5,4‐d]pyrimidinone derivatives as cholinesterase inhibitors against Alzheimer's disease
Yan Zeng, Lifei Nie, Liu Liu +6
ArticleCholinesterase and Neurodegenerative DiseasesJournal of Heterocyclic Chemistry202217 citations
ABI
Diversity-oriented synthesis of amide derivatives of tricyclic thieno[2,3- d ]pyrimidin-4(3 H )-ones and evaluation of their influence on melanin synthesis in murine B16 cells
Li Fei Nie, Guozheng Huang, Khurshed Bozorov +4
ArticleSynthesis of Organic CompoundsHeterocyclic Communications201815 citations
ABI
<scp>2‐substituted</scp> tricyclic oxazolo[5,4‐d]pyrimidine library: Design, synthesis, and cytotoxicity activity
Yan Zeng, Lifei Nie, Khurshed Bozorov +4
ArticleQuinazolinone synthesis and applicationsJournal of Heterocyclic Chemistry202111 citations
ABI
Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation
Fang Ma, Hongtao Du
Article20176 citations
ABI
Discovery of deoxyvasicinone derivatives as inhibitors of NEDD8-activating enzyme
Hai‐Jing Zhong, Ka‐Ho Leung, Sheng Lin +5
Article20145 citations
ABI
Novel Deoxyvasicinone–Donepezil Hybrids as Potential Multitarget Drug Candidates for Alzheimer’s Disease
Hongtao Du, Xinlian Liu, Jusen Xie +1
Article20195 citations
ABI
Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with ‘inverted’ binding mode
Fouad H. Darras, Sarah Wehle, Guozheng Huang +2
Article20143 citations
ABI
Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease
Muriel Noetzli, Chin B. Eap
Review article20133 citations
ABI
Pharmacogenetic Considerations in the Treatment of Alzheimer’s Disease
Ramón Cacabelos, Clara Torrellas, Óscar Teijido +1
Review article20163 citations
ABI
Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology
Md. Sahab Uddin, Abdullah Al Mamun, Md. Tanvir Kabir +4
Review article20183 citations
ABI
A review on cholinesterase inhibitors for Alzheimer’s disease
Preet Anand, Baldev Singh
Review article20132 citations
ABI
Peroxide-Mediated Oxidative Radical Cyclization to the Quinazolinone System: Efficient Syntheses of Deoxyvasicinone, Mackinazolinone and (±)-Leucomidine C
Luis D. Miranda, Jazmín García-Ramírez
Article20202 citations
ABI
Crystal structure, Hirshfeld surface analysis and energy framework study of 6-formyl-7,8,9,11-tetrahydro-5H-pyrido[2,1-b]quinazolin-11-one
Akmaljon Tojiboev, Sherzod Zhurakulov, Валентина И. Виноградова +2
ArticleQuinazolinone synthesis and applicationsActa Crystallographica Section E Crystallographic Communications20202 citations
ABI
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
Elisabet Viayna, Nicolas Coquelle, Monika Cieslikiewicz‐Bouet +23
Article20202 citations
ABI
Discovery of Novel Tacrine–Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer’s Disease
Hong Yao, Giuseppe Uras, Pengfei Zhang +11
Article20212 citations
ABI
Untitled
Other1 citations
ABI
Untitled
Other1 citations
ABI
Untitled
Other1 citations
ABI
Untitled
Other1 citations
ABI

Works cited by this work

Design, synthesis, in vitro evaluation of a new pyrrolo[1,2‐<i>a</i>]thiazolo[5,4‐<i>d</i>]pyrimidinone derivatives as cholinesterase inhibitors against Alzheimer's disease

Diversity-oriented synthesis of amide derivatives of tricyclic thieno[2,3- <i>d</i> ]pyrimidin-4(3 <i>H</i> )-ones and evaluation of their influence on melanin synthesis in murine B16 cells

<scp>2‐substituted</scp> tricyclic oxazolo[5,4‐<i>d</i>]pyrimidine library: Design, synthesis, and cytotoxicity activity

Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation

Discovery of deoxyvasicinone derivatives as inhibitors of NEDD8-activating enzyme

Novel Deoxyvasicinone–Donepezil Hybrids as Potential Multitarget Drug Candidates for Alzheimer’s Disease

Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with ‘inverted’ binding mode

Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease

Pharmacogenetic Considerations in the Treatment of Alzheimer’s Disease

Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology

A review on cholinesterase inhibitors for Alzheimer’s disease

Peroxide-Mediated Oxidative Radical Cyclization to the Quinazolinone System: Efficient Syntheses of Deoxyvasicinone, Mackinazolinone and (±)-Leucomidine C

Crystal structure, Hirshfeld surface analysis and energy framework study of 6-formyl-7,8,9,11-tetrahydro-5<i>H</i>-pyrido[2,1-<i>b</i>]quinazolin-11-one

Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice

Discovery of Novel Tacrine–Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer’s Disease

Untitled

Untitled

Untitled

Untitled